Home

Unite Janice Minefield buffett biogen TV set rehearsal typist

Buffett's Berkshire buys Kroger and Biogen, reduces Wells Fargo and Goldman stakes | Reuters
Buffett's Berkshire buys Kroger and Biogen, reduces Wells Fargo and Goldman stakes | Reuters

Warren Buffett's Berkshire Hathaway settles on its first biotech investment
Warren Buffett's Berkshire Hathaway settles on its first biotech investment

Warren Buffetts Berkshire Hathaway har sålt allt i Biogen
Warren Buffetts Berkshire Hathaway har sålt allt i Biogen

Warren Buffett's Berkshire Hathaway makes big bet on drug stocks | CNN Business
Warren Buffett's Berkshire Hathaway makes big bet on drug stocks | CNN Business

PG: 4 Warren Buffett Stocks to Buy and Never Sell
PG: 4 Warren Buffett Stocks to Buy and Never Sell

Buffett's Berkshire cuts U.S. drugmaker stakes, invests in drug royalty company | Reuters
Buffett's Berkshire cuts U.S. drugmaker stakes, invests in drug royalty company | Reuters

15 Stocks Warren Buffett Is Buying (And 7 He's Selling) | Kiplinger
15 Stocks Warren Buffett Is Buying (And 7 He's Selling) | Kiplinger

Buffett Is Poised to Address Missed Deals With Cash Pile Growing - Bloomberg
Buffett Is Poised to Address Missed Deals With Cash Pile Growing - Bloomberg

Warren Buffett just revealed position in Kroger and these other stocks
Warren Buffett just revealed position in Kroger and these other stocks

Why Warren Buffett's Riskiest Bet in Years Is on the Brink of Bombing | The Motley Fool
Why Warren Buffett's Riskiest Bet in Years Is on the Brink of Bombing | The Motley Fool

10 Stocks Warren Buffett Is Selling (And 7 He's Buying) | Kiplinger
10 Stocks Warren Buffett Is Selling (And 7 He's Buying) | Kiplinger

Apple, GM, Kroger, AbbVie, Merck, Bristol Myers Squibb, Biogen — How Warren Buffett's Berkshire Adjusted Its Portfolio In Q2
Apple, GM, Kroger, AbbVie, Merck, Bristol Myers Squibb, Biogen — How Warren Buffett's Berkshire Adjusted Its Portfolio In Q2

Billionaire Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen | The Star
Billionaire Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen | The Star

9 Stocks That Pass the Warren Buffett Buy Test
9 Stocks That Pass the Warren Buffett Buy Test

Buffett's Berkshire Adds Biogen, Kroger Stakes; Stocks Climb - Bloomberg
Buffett's Berkshire Adds Biogen, Kroger Stakes; Stocks Climb - Bloomberg

Warren Buffett Makes Biogen Stock Gain As FDA Approves Alzheimer's Drug
Warren Buffett Makes Biogen Stock Gain As FDA Approves Alzheimer's Drug

Berkshire Hathaway sold over $800M in Apple shares in Q1 2020 | AppleInsider
Berkshire Hathaway sold over $800M in Apple shares in Q1 2020 | AppleInsider

Warren Buffett, Berkshire Sold Biogen Stock, Grew Kroger Stake in Q2
Warren Buffett, Berkshire Sold Biogen Stock, Grew Kroger Stake in Q2

Warren Buffet's Berkshire Hathaway cuts Merck stakes, invests in drug royalty company - BusinessToday
Warren Buffet's Berkshire Hathaway cuts Merck stakes, invests in drug royalty company - BusinessToday

Warren Buffett makes big investment in US pharmaceutical firms | Pharmaceuticals industry | The Guardian
Warren Buffett makes big investment in US pharmaceutical firms | Pharmaceuticals industry | The Guardian

Warren Buffett: 3 Liberty Global plc transactions (Berkshire Hathaway
Warren Buffett: 3 Liberty Global plc transactions (Berkshire Hathaway

Warren Buffett's Berkshire Hathaway sheds Axalta, Biogen; buys Organon | Mint
Warren Buffett's Berkshire Hathaway sheds Axalta, Biogen; buys Organon | Mint

Warum Buffett-Investment Biogen nicht vom Biotech-Trend profitieren kann | 23.01.21 | finanzen.ch
Warum Buffett-Investment Biogen nicht vom Biotech-Trend profitieren kann | 23.01.21 | finanzen.ch

Warren Buffett Sold Off This Biotech Stock. Should You? | The Motley Fool
Warren Buffett Sold Off This Biotech Stock. Should You? | The Motley Fool

Warren Buffett Buys Kroger, Biogen In 4th Quarter
Warren Buffett Buys Kroger, Biogen In 4th Quarter

Warren Buffett, Berkshire Sold Biogen Stock in Q2, Slashed Pharma Bets
Warren Buffett, Berkshire Sold Biogen Stock in Q2, Slashed Pharma Bets